DrugsControl Media Services
DrugsControl.org

News Detail

US FDA to Reclassify Hepatitis B Virus Tests as Moderate Risk Devices (27-09-2024)

NEW YORK, 27 SEPT 2024: The US Food and Drug Administration said Tuesday that it plans to reclassify several types of qualitative and quantitative hepatitis B virus (HBV) tests as moderate risk Class II devices from their current classification as high-risk Class III devices.

......
View Details
Source : 360info
government federal register executive rulings notices

Related News